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Background: Having an estimate of the measurement error of self-report questionnaires is important both for
assessing follow-up results after treatment and when planning intervention studies. Specific questionnaires have
been evaluated for patients with shoulder instability, but not in particular for patients with SLAP (superior labral
anterior posterior) lesions or recurrent dislocations. The aim of this study was to evaluate the agreement, reliability,
and validity of two commonly questionnaires developed for patients with shoulder instability and a generic
questionnaire in patients with SLAP lesions or recurrent anterior shoulder dislocations.
Methods: Seventy-one patients were included, 33 had recurrent anterior dislocations and 38 had a SLAP lesion. The
patients filled in the questionnaires twice at the same time of the day (± 2 hours) with a one week interval
between administrations. We tested the Oxford Instability Shoulder Score (OISS) (range 12 to 60), the Western
Ontario Shoulder Instability Index (WOSI) (0 to 2100), and the EuroQol: EQ-5D (−0.5 to 1.0) and EQ-VAS (0 to 100).
Hypotheses were defined to test validity.
Results: ICC ranged from 0.89 (95% CI 0.83 to 0.93) to 0.92 (0.87 to 0.95) for OISS, WOSI, and EQ-VAS and was 0.66
(0.50 to 0.77) for EQ-5D. The limits of agreement for the scores were: -7.8 to 8.4 for OISS; -339.9 to 344.8 for WOSI; -
0.4 to 0.4 for EQ-5D; and −17.2 and 16.2 for EQ-VAS. All questionnaires reflect the construct that was measured. The
correlation between WOSI and OISS was 0.73 and ranged from 0.49 to 0.54 between the shoulder questionnaires
and the generic questionnaires. The divergent validity was acceptable, convergent validity failed, and known group
validity was acceptable only for OISS.
Conclusion: Measurement errors and limitations in validity should be considered when change scores of OISS and
WOSI are interpreted in patients with SLAP lesions or recurrent shoulder dislocations. EQ-5D is not recommended
as a single outcome.
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A number of self-report questionnaires have been de-
veloped to assess shoulder pain and disability from the
patient’s perspective. The choice of a questionnaire may
be based on factors such as study or diagnostic group,
practical considerations regarding the ease of scoring,
and the time to fill in the questionnaire as well as
clinometric properties. A recent study reported that
a general shoulder questionnaire was as good as the
disease specific Western Ontario Rotator Cuff Index
(WORC) and Oxford Shoulder Score (OSS) for rotator
cuff disease [1]. Thus, the need for disease specific
questionnaires for all different kinds of shoulder diag-
noses can be questioned.
Shoulder instability can be defined as the loss of shoul-
der comfort and function due to undesirable translation
of the humeral head on the glenoid [2]. From the patient
perspective, shoulder instability may be defined as symp-
tomatic abnormal motion of the glenohumeral joint
which can present as pain or a sense of displacement
(subluxation or dislocation) [3]. From a diagnostic point
of view, instability is difficult to verify unless a disloca-
tion has occurred. The latter is defined as a complete
dissociation of the articular surfaces documented radio-
graphically or by a manual reduction manoeuvre [4]. In
patients with anterior shoulder dislocation, the main
patho-anatomical finding is the Bankart lesions with
avulsion of the labrum and the glenohumeral ligament
from the anterior-inferior glenoid rim. A superior labral
anterior posterior (SLAP) lesion of the shoulder is a rela-
tively rare condition caused by injury or degeneration of
the superior part of the glenoid labrum. Apprehension
and loss of confidence are reported to be the major fac-
tors inhibiting sports activities and decreasing quality
of life in patients with recurrent dislocations [5,6],
while pain, popping, clicking, catching, weakness, stiff-
ness, and instability (apprehension and loss of confi-
dence) are reported in patients with SLAP lesions [7]
Symptoms overlap in the two patients groups as those
with recurrent dislocations also may experience pain,
popping, clicking, stiffness, and weakness.
Several questionnaires have been designed to evaluate
treatment of instability in the shoulder while specific
questionnaires have not been published for patients with
SLAP lesions. In the original study the Western Ontario
Shoulder Instability Index (WOSI) was evaluated in 33
patients with shoulder instability, but not in particular
for patients with recurrent shoulder dislocations [2]. Ox-
ford Instability Shoulder Score (OISS) was evaluated in
53 patients diagnosed as having either unidirectional or
multidirectional instability [6]. In a 5-year follow-up
study of arthroscopic repair in patients with SLAP le-
sions [8], the clinical Rowe Score (1988 version) was
used as the main effect variable. This score has beenreported to have considerable limitations [9] and results
[8] would have been strengthened applying a self-report
outcome with acceptable measurement properties.
In absence of a disease-specific scoring system for
SLAP lesions, existing questionnaires for shoulder in-
stability [10], such as the OISS [11] and the WOSI [2],
offer a possible alternative for the assessment of treat-
ment effects in patients with SLAP lesions, because both
conditions includes labral lesions that may cause similar
symptoms.
The generic EuroQol provides an utility index for use in
cost-effectiveness studies and for the comparison of results
across different patient populations [12]. Most researchers
advocate that studies of comparative effectiveness include
a generic measurement of quality of life to allow for com-
parisons across patient populations [13,14].
The original studies of WOSI reported Interclass Cor-
relation Coefficients (ICCs) for evaluation of reliability,
but did not report agreement statistics [2]. Reliability
describes the consistency of the test-retest variation
within an individual relative to the variation between
individuals in the group. The measurement error within
a patient is best described by agreement parameters
which estimate how close the results of repeated mea-
sures are. Agreement parameters have direct impact on
reliability, effect size, responsiveness, and sample size
calculations [15,16].
Self-report questionnaires are applied to evaluate the
change in a patient or a group of patients following
treatment or to evaluate the change between treatments
in a clinical trial. It is important that both reliability and
agreement are evaluated in methodological studies. Be-
sides, other quality criteria of the instruments should be
assessed. By example summarizing of the items in a scale
is supported if the internal consistency or Chronbach’s
alpha is high and indicate that the same concept is mea-
sured [17]. Correlation is often used to examine the as-
sociation between different outcomes for evaluation of
whether they can be used interchangeably. There is an
ongoing debate about the interpretation of correlation as a
measure of construct validity. The COSMIN (COnsensus-
based Standards for the selection of health status Meas-
urement INstruments) group have recommended to use
hypotheses testing to assess various aspects of validity
which include construct, convergent, divergent, and
known group validity of an instrument [18].
The purpose of the present study was to cross-culturally
adapt OISS and WOSI for use in Norwegian-speaking pa-
tients, and evaluate the agreement, inter-rater and intra-
rater reliability, content- and construct validity of the
Oxford Instability Shoulder Score, the Western Ontario
Shoulder Instability Index, and the EuroQol in patients
with recurrent anterior shoulder dislocations or SLAP
lesions.
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Study population and study design
Between November 2006 and August 2008, 103 patients
referred for shoulder surgery at the Orthopaedic Depart-
ment at Lovisenberg Diaconal Hospital in Oslo, Norway,
were prospectively recruited. Eighty-five patients aged
16–60 years with a symptom duration of at least 3
months met the inclusion criteria for the study [9]. All
patients signed an informed consent. The present study
is approved by The Ethical Committee of Health Region
South-East, Norway. Seventy-one patients (33 had recur-
rent anterior (at least two) dislocations and 38 had a
SLAP lesion) were included. Patients with symptoms
and signs suggesting a SLAP lesion were included if the
lesion was confirmed on MRI arthrography [9]. Patients
labelled SLAP lesion were not included if they had a his-
tory of shoulder dislocation. The exclusion criteria for the
study were posterior or multidirectional dislocations; in-
ability to complete the questionnaires; previous surgery
for SLAP injuries or instability in the same shoulder;
rheumatic disease affecting the symptomatic shoulder;
pain referred from the cervical or thoracic spine; and se-
vere somatic or psychiatric disorders. All included patients
gave a written informed consent.
The patients completed OISS, WOSI, the 1988 version
of Rowe Score, and EuroQol questionnaire twice, at the
same time of the day with a one week interval between
administrations. The test-retest period was chosen to re-
duce recall bias. One patient was excluded at retesting
because he reported major changes in his activity level,
and deterioration between tests.
Questionnaires
OISS is a disease-specific health-related quality-of-life
self-report questionnaire, for use in patients with shoul-
der instability [6]. Several names and abbreviations have
been used synonymously, such as Oxford Instability
Score (OIS) [19] and Shoulder Instability Questionnaire
(SIQ) [20]. The instrument consists of 12 questions,
each of which had five response alternatives, ranked
from least to most difficult (1–5 points). The items
cover episodes of instability, daily activities, pain, work,
social life, sports/hobbies, attention to the shoulder
problem, lifting, and lying positions with a total pos-
sible score ranging from 12 (best function) to 60 (worst
function) [6].
WOSI consists of 21 self-report questions representing
four domains (sports, recreation/work, lifestyle and
emotions). Each question is answered on visual analogue
scale ranging from 0 (best) to 100 (worst). The total
score ranges from 0 (best) to 2100 (worst) [2].
The EuroQuol is a generic health-related quality-of-life
instrument [12,21,22]. EQ-5D consists of five domains
(mobility, self-care, usual activities, pain/discomfort, andanxiety/depression), with three levels corresponding to
no problem, some problem and an extreme problem.
The responses are transformed into a utility index and
are then classified into 243 (35) health states ranging
from the best imaginable state (1.0), and worst possible
score (0.59). EQ-VAS estimates generic health status by
using a visual analogue scale from 0 (worst possible) to
100 (best possible).
For assessment of the correlation between scores we
also included the 1988 version of the clinical Rowe
Score [9,23].
Translation
The EQ-5D was already cross-culturally adapted for use
in Norwegian-speaking population [24]. Cross-cultural
adaptations of the Norwegian versions of OISS and
WOSI was conducted according to the procedures de-
scribed in the literature [25,26]. Forward translation of
OISS and WOSI was done by two bilingual medical doc-
tors, one bilingual nurse and one bilingual medical doc-
tor and professional translator. Two had Norwegian as
their native language and two had English as their native
language. The translations were done independent of
each other and then compared. The Norwegian versions
were then back-translated into English by a professional
translator. The back-translated versions were then
reviewed and inconsistencies of the items of OISS and
WOSI were discussed and approved in a consensus
meeting with the four translators.
Statistical analysis
The study was planned to have a sample size of at least
50 patients, which is the general recommendation given
by Altman for a methods comparison study [27]. All pa-
tients had chronic complaints and we assumed that
diagnostic group did not influence agreement statistics.
For reliability and validity evaluation we could not ex-
clude that diagnostic group may influence results and
some exploratory analyses were performed in each diag-
nostic group.
Age, duration of symptoms, and number of disloca-
tions were described by median (range) while numbers
(percentages) are reported for gender, manual labour,
physical activity level, and whether the dominant shoul-
der was involved. Means (SD) were used for descriptive
statistics for total scores and domain scores of WOSI
and for the total scores of OISS, EQ-5D and EQ-VAS.
The data of the descriptive statistics data followed a
normal distribution. Differences between groups were
compared by Student’s two-sample t-test, Chi-square
was used for categorical variables. Minimum and max-
imum scores for individual items, domain and total
scores were examined for possible floor and ceiling ef-
fects, which were considered to be present if more than
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respectively.
Internal consistency describes the correlations among
items measuring the same concept on questionnaire
(sub)scales [17], A Chronbach’s alpha between 0.70 and
0.95, indicates strong correlation between items in a
scale [17,18]. We calculated the internal consistency for
the total scores and domain scores.
Test –retest reliability is commonly tested by ICC.
which combines the within and between patient vari-
ation from 0 (no reliability) to 1 (perfect reliability).
According to Terwee et al., an ICC > 0.70 is considered
to be acceptable [17]. We used a two-way random single
measure (ICC 2.1), with a 95% confidence interval for
the total score and for the domains [17,28].
Agreement describes the within patient measurement
error, and indicates how close the scores of repeated
measurements are to one another [17]. Statistical
methods to estimate measurement error include stand-
ard error of measurement (SEM), limits of agreement
(LoA), and minimal detect able change (MDC) which
equals the repeatability coefficient [17,18,29]. SEM is
recommended as the measure of agreement [18]. It
can be estimated as SEMconsistency (SD√(1-ICC)) or
SEMagreement (within- subject standard deviation (Sw)).
The latter is obtained by extracting the square root of
the residual mean square, using one-way ANOVA with
subjects as the factor [30,31]. While the SEMconsistency
include both between and within-subject variations,
SEMagreement takes only the within-subjects variation into
account. The COSMIN checklist for does not give infor-
mation about a particular version of SEM [18,32,33]. In
the present study, we estimated SEMagreement, minimal de-
tectable change (SEM × 1.96√2) and limits of agreement
(mean individual difference ± SD of differences) with 95%
confidence interval. We constructed agreement plots
according to Bland and Altmann [34].
Validity describes whether an instrument measures
what it is intended to [13].
Content validity indicates that the concepts of interest
are comprehensively represented by the items in the
questionnaire [32,35]. Terwee et al. recommended that
authors should provide clear descriptions aims of the
questionnaire, the target population, the concepts
intended to be measured, item selection, reduction and
interpretability [17]. According to the COSMIN check-
list [32], content validity should be assessed by making a
judgment about the relevance and comprehensiveness of
the items. Patients or experts should be asked whether
they missed any items. In the present study, this was
checked during the cross cultural adaptation process
and by assessing floor and ceiling effects of the domains
and single questions of the instruments [17,32]. Large
floor and ceiling effects suggest that content validity islow. Floor and ceiling effects were considered apparent
if 15% or more of the responders had the lowest or the
highest possible score, respectively.
Construct validity means that questionnaire measures
the relevant constructs [33]. The COSMIN checklist rec-
ommends to use hypotheses to test relationships with
other instruments or differences among relevant groups
[32]. Construct validity is considered acceptable when at
least 75% of the hypotheses are accepted [17]. To admit
comparison of construct validity with other studies not
using hypotheses, Pearsons correlation coefficient be-
tween OISS, WOSI, EQ-5D, EQ-VAS and the 1988 ver-
sion of Rowe Score was obtained.
There are several aspects of construct validity which
include convergent, divergent/discriminant, and known
group validity. Convergent validity reflects correlation
with other instruments that measure the same properties
[39]12. Convergent validity for hypotheses 1 to 8 was
tested using Pearsons correlation coefficient. R > 0.70
was regarded as positive correlation [17]. Divergent val-
idity/discriminant validity evaluates whether concepts of
measures that are supposed to be unrelated are in fact
unrelated [36]. Tests can be invalidated by too high cor-
relations with other tests they were intended to differ
[36]. In the present study the formula rxy /√(rxx * ryy)
was used to test discriminant validity [36]. Hypotheses
12 and 13 were tested using the formula rxy /√(rxx * ryy),
where rxy is the correlation between EQ-5D and OISS
and WOSI, rxx is the ICC of OISS or WOSI, and the ryy
is the ICC of EQ-5D. A result <0.85 is considered to in-
dicate acceptable discriminant validity [36]. Known group
validity describes the relationships among different
groups (age, gender, diagnosis, etc.). Independent sample
t- tests were used to test known group validity for hy-
potheses 9 to 11.
Hypotheses
Convergent validity (positively correlated means r > 0.70)
1. WOSI should be positively correlated OISS.
2. WOSI should be positively correlated with Rowe
Score.
3. OISS should be positively correlated with Rowe
Score.
4. WOSI part B (Sports/Recreation/Work) should be
positively correlated with question 8 of OISS:
“During the last four weeks, how much has the
problem with your shoulder interfered with your
sporting activities or hobbies?”
5. WOSI part D (Emotions) should be positively
correlated with question 9 of OISS: “During the
last four weeks, how often has your shoulder been
«on your mind”- how often have you thought
about it?”
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correlated with question 12 of OISS: “During the
last four weeks, have you avoided lying in certain
positions in the bed at night because of your
shoulder?”
7. WOSI part A (Physical symptoms) should be
positively correlated with question 3 of OISS:
“During the last three months, how would you
describe the worst pain you have had from your
shoulder?”
8. Question 1 of OISS — “During the last six months,
how many times has your shoulder slipped out of
joint (or dislocated)?” — should be correlated with
question 8 of WOSI part A: “How much feeling of
instability or looseness do you experience in your
shoulder?”
Known group validity
9. OISS should be the same for patients < 45 and > 45
years old.
10. WOSI should be the same for patients< 45 and > 45
years old.
11. The scores of the SLAP group should be negatively
correlated (R < 0.70) with the scores of the
instability group of question 1 of OISS: “During the
last six months, how many times has your shoulder
slipped out of joint (or dislocated)?”.
Divergent/discriminant validity
12. The discriminate validity between OISS and EQ-5D
should be < 0.85.
13. The discriminate validity between WOSI and EQ-
5D should be < 0.85. The analysis was performed
using Statistical Analysis System software (SAS,
version 9.2, SAS Institute Inc., Cary NC, USA).
Results
Demographics
Fifty men (70.4%) and 21 women (29.6%) were included
for further analysis in this study (Table 1). There were
no differences in baseline characteristics among the 14
patients who were excluded, compared with those pa-
tients who were included. The patients in the instability
group were younger than the SLAP group and had a me-
dian of 10 (range 2 to 40) dislocations. The two diagnos-
tic groups did not differ on the mean scores of the
questionnaires.
Cross cultural validity
The EuroQol instrument was already cross-culturally
adapted into Norwegian [24]. The relevance and transla-
tions of items of OISS and WOSI were discussed andapproved by the consensus group. The translated ver-
sions of OISS and WOSI adequately reflected items in
the original-language versions.Internal consistency
Chronbach’s alpha for the total scores of OISS, WOSI,
and EQ-VAS was ranged from 0.94 to 0.96 (Table 2).
There Chronbach’s alpha was 0.79 for EQ index and
ranged from 0.87 to 0.96 for the domains of WOSI
(Table 2).Test-retest reliability
ICC ranged from 0.89 (95% CI 0.83 to 0.93) to 0.92 (0.87
to 0.95) for the total scores of OISS, WOSI, and EQ-
VAS and was 0.66 (0.50 to 0.77) for EQ-5D (Table 2).
For the domains of WOSI, ICCs ranged from 0.77 (0.65
to 0.85) to 0.92 (0.88 to 0.95) (Table 3). ICC ranged from
0.01 (−0.22 to 0.24) to 0.75 (0.63 to 0.84) for the do-
mains; walking, personal care, and daily activities of EQ-
5D (Table 4).Agreement
There were no significant differences between the first
and second administration of the scores (Table 2) or be-
tween diagnostic groups (Table 1). SEMagreement for the
total score were 2.9 for the OISS; 122.4 for the WOSI;
0.1 for the EQ-5D; and 6.0 for the EQ-VAS (Table 2).
The minimal detectable change for the total scores was
8.1 points for the OISS; 339.3 points for the WOSI; 0.4
points for the EQ-5D; and 16.6 points for the EQ-VAS
(Table 2). For the total scores, the limits of agreement
were −7.8 to 8.4 for the OISS; -333.9 to 344.8 for the
WOSI; -0.4 to 0.4 for the EQ-5D; and −17.1 to 16.2 for
the EQ-VAS (Table 2). For the domains of the WOSI
and the EQ-5D, the results are given in Tables 3 and 4
respectively. The limits of agreement plots are shown in
Figure 1.Content validity
The OISS, the WOSI, and the EuroQol reflected the
construct to be measured. However, in this study, 4 of
the 38 patients with SLAP lesions reported experiencing
shoulder dislocation over the previous 6 months (Ques-
tion 1, OISS). There were no floor and ceiling effects for
the total score of OISS or the single item scores, the do-
main scores, and the total score of WOSI. For single
items of OISS, floor effects were observed for question 1
(shoulder instability) in the SLAP group and in both
groups for question 2, 7, and 12, and ceiling effects for
question 7, 9, 10, and 12. For EQ-5D the floor effects
ranged from 22% to 97% (Table 4).
Table 1 Descriptive statistics
SLAP Instability
Males/females [n] 28/10 22/11
Age (median [range]) 40 (16–60) 25 (19–54)
Duration of symptoms median months (range) 23 (4–132) 36 (10 – 360)
Manual labour n (%) 21 (55.3) 14 (42.4)
Physical activity
competition 4 (10.5) 5 (15.2)
weekly or more 20 (52.6) 20 (60.6)
none 14 (36.8) 8 (24.2)
Shoulder involved; right/left 27/11 14/19
Dominant shoulder involved n (%) 26 (68) 15 (45)
Number of dislocations median (range) 0 10 (2 – 40)
WOSI total score 1081.7 (382.8) 1025.8 (438.9)
OISS total score 37.4 (7.6) 33.7 (10.4)
EQ-5D index 0.65 (0.22) 0.76 (0.25)
EQ-VAS 71.2 (15.0) 72.7 (21.3)
Rowe total score 66.9 (10.6) 63.9 (11.0)
SLAP superior glenoid labrum lesions, WOSI Western Ontario shoulder Instability Index, OISS Oxford Instability Shoulder Score, EQ-5D, EQ-VAS, EuroQol. Rowe score;
1988 version. Scores are given for first evaluation.
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There were no missing items. The correlation between
WOSI and OISS was; 0.64 (95% CI 0.41 to 0.80)for the
SLAP group and 0.80 (95%CI 0.62 to 0.69) for recurrent
dislocations. The correlations between the specific ques-
tionnaires and EQ-5D and EQ-VAS ranged from −0.27
(95% CI −0.54 to 0.05) to −0.59 (95% CI – 0.79 to 0.32)
with r < 0.60 for both diagnostic groups. The Rowe score
correlated −0.42 (95% CI −0.67 to −0.09) with WOSI
for the SLAP group, and −0.59 (95% CI −0.76 to −0.33)
for the recurrent dislocation group, r < 0.60 in both
groups. The correlation between the Rowe score and






















5.4 (−35.6 to 36.4) (−333.9 to 344.8
EQ-5D
(−0.53 to 1)
0.70 (.24) 0.71 (0.24) −0.01 (−0.06 to 0.04) (−0.4 to 0.4)
EQ-VAS
(0 to 100)
71.9 (18.1) 72.3 (18.7) −0.42 (−2.4 to 1.6) (−17.1 to 16.2)
SD standard deviation, ICC (2.1) interclass correlation version 2.1 for measuring corr
between test and retest, the limits of agreement (LoA), the standard error of measu
confidence interval. Chronbach’s alpha (internal consistency) are given for the 2.tes
difference between test and retest score.
† P< .0001 for all ICC (interclass correlation coefficient version 2.1).dislocation group, and −0.45 (95%CI −0.67 to −0.15) for
the SLAP group r < 0.60 in both groups.
Convergent validity
Hypotheses (1 to 8) failed (r > 0.70 only for hypothesis 1).
Known group validity
Hypotheses (9 to 11) failed (p<0.05 only for OISS, hy-
pothesis 9).
Divergent/discriminant validity
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122.4 0.96
0.4 (0.3 to 0.5) 0.66 (0.50
to 0.77)
0.1 0.79
16.6 (11.2 to 22.2) 0.89 (0.83
to 0.93)
6.0 0.94
elation between test and retest. Agreement estimated by the difference
rement (SEMagreement), and minimal detectable change (MDC) with 95%
t. 95% CI (confidence interval) for paired t-test under null hypothesis = no






















Physical symptoms 452 (−171.4 to 54.3) 0.92 (0.88
to 0.95)






243 (21, 398) (−96.6 to 118.5) 0.82 (0.72
to 0.88)
0 0 107.6 (72.0
to 143.2)
38.8 0.90
Lifestyle 190 (4, 399) (−103.5 to 106.5) 0.87 (0.81
to 0.92)
0 0 105.0 (70.2
to 139.8)
37.8 0.93
Emotions 206 (2, 299) (−91.2 to 116.2) 0.77 (0.65
to 0.85)
0 0 103.7 (69.3
to 138.1)
37.4 0.87
ICC (2.1), interclass correlation version 2.1 for measuring correlation between test and retest. Agreement estimated by the difference between test and retest,
minimal detectable change (MDC) with 95% confidence interval, standard error of measurement (SEMagreement), and limits of agreement (LoA). Chronbachs alpha
(internal consistency) are given for the 2.test. Content validity is measured by floor and ceiling effects.
95% CI (confidence interval) for paired t-test under null hypothesis = no difference between test and retest score.
† P< .0001 for all ICC (interclass correlation coefficient version 2.1).
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This study contributes to the knowledge about the reli-
ability, agreement and validity of OISS, WOSI, EQ-5D,
and EQ-VAS in patients with SLAP-lesions or recurrent
anterior shoulder instability.
Internal consistency
The internal consistency for OISS was slightly different
from that reported by the developers [6]. Because there
are no domains in OISS, the internal consistency covers
the total score of all 12 items. For WOSI findings are in
keeping previous versions [37,38], but higher than those
reported for the domain lifestyle [39,40]. For EQ-VAS,
the Chronbach’s alpha was in keeping with the results of
Adobor et al. [41], slightly lower for EQ-5D.
Reliability
ICC for the OISS was comparable with the results of
Moser et al. [42]. For the WOSI, it was in accordance
with the original version and later published versions
[2,37,38], and for EQ-VAS it was slightly higher than












Walking 0.00 (0, 1) (−0.30 to 0.35) 97.2 0.0
Personal care 0.00 (0, 1) (−0.63 to 0.61) 84.5 0.0
Daily activities 1.00 (0, 2) (−0.85 to 1.04) 29.6 5.6
Pain/discomfort 1.00 (0, 2) (− 0.73 to 0.81) 22.5 9.9
Anxiety/depression 0.00 (0, 1) (−0.66 to 0.57) 79.1 0.0
ICC (2.1), interclass correlation version 2.1 for measuring correlation between test an
minimal detectable change (MDC) with 95% confidence interval, limits of agreemen
measured by floor and ceiling effects.
95% CI (confidence interval) for paired t-test under null hypothesis = no difference
† p < 0,0001 for all ICC’s (interclass correlation coefficient version 2.1) except for thestudies the reliability of EQ-5D was not acceptable in
the present study [12,41].
Agreement
Agreement of OISS, reported by standard error of mea-
surements and minimal detectable change were in the
same range as reported by Moser et al. [42]. When
interpreting minimal detectable change in a patient, a dif-
ference of test and retest score of < 8.1 is within measure-
ment error. The same interpretation can be made for the
other instruments reading Tables 2, 3 and 4. The measure-
ment error found for WOSI (Tables 2 and 3) is larger than
the findings of Cacchio et al. [37], reporting SEMconsistency
of 71 points and minimal detectable change of 196
points. The differences may be attributed the use of dif-
ferent versions of SEM and methods to calculate min-
imal detectable change.
Because ICC depends on both within- and between-
subjects variation, it can be misleadingly high, and SEM
correspondingly lower, if the between-subjects variation
is high. As pointed out by Weir [28], also different ver-











0.3 (0.2 to 0.4) 0.01 (−0.22 to 0.24) 0.2
0.6 (0.4 to 0.8) 0.65 (0.49 to 0.77) 0.2
0.9 (0.6 to 1.2) 0.63 (0.47 to 0.75) 0.3
0.8 (0.5 to 1.1) 0.73 (0.60 to 0.82) 0.3
0.6 (0.4 to 0.8) 0.75 (0.63 to 0.84) 0.2
d retest. Agreement estimated by the difference between test and retest,
t (LoA), and standard error of measurement (SEMagreemen). Content validity is
between test and retest score.
domain walking (p = 0.93).
Figure 1 Limits of agreement plots. Average of 1. and 2.test total scores of OISS, WOSI EQ-5D, and EQ-VAS. On each plot, the central line
represents the mean of the scores and the flanking lines represents the 95% limits of agreement.
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represents a problem for comparison between studies.
SEM estimated as the square root of the mean square
error term from the ANOVA avoids this problem, al-
though the results will differ depending on the application
of a one-way model or a two-way model as well as specifi-
cation of fixed effects or random (individual) effects. The
limits of agreement is not affected by the various methods
used for calculating the ICC and SEM, and represents a
uniform estimate of the measurement error that is easier
to compare between studies. As shown in Tables 2 and 3,
the limits of agreement were considerable for all question-
naires. For EQ-5D limits between −0.4 and 0.4 on a scale
ranging from - 0.53 to 1 means that this index is imprecise
for estimating true change in an individual patient.Content validity
In agreement with previous studies [2,6,12,37-43], all
the questionnaires reflected the constructs to be mea-
sured. One of the aims of the present study was to
evaluate the questionnaires for use in studies with pa-
tients with SLAP lesions, as the original versions of the
OISS and WOSI were developed for use in patients
with instability. Question 1 in OISS — During the last
six months, how many times has your shoulder slipped
out of joint (or dislocated)? — is not expected to be
relevant for patients with superior labral tears (SLAP II
lesions). However, 4 of 38 patients answered that their
shoulder had slipped out of the joint, suggesting that
they had the experience that this had occurred, or that
they did not understand the question. Unfortunately,
Skare et al. BMC Research Notes 2013, 6:273 Page 9 of 10
http://www.biomedcentral.com/1756-0500/6/273we did not interview the patients about how they
interpreted this question.
The good content validity of the total scores of OISS
and WOSI was supported by the absence of floor and
ceiling effects for these questionnaires. Although single
items of OISS had considerable floor and/or ceiling ef-
fects for both diagnostic groups, there were no floor or
ceiling effects for single items of WOSI using the 15%
definition. As noted by Ekeberg et al., agreement param-
eters can be overestimated when floor and ceiling effects
appear, as an extreme value is more likely to be repeated
in a retest [1]. The considerable floor effects of EQ-5D
call into question the use of this generic self-report
index in the population examined. The floor effects of
EQ-5D suggest that health-related quality is not much
affected by a SLAP-lesion or recurrent dislocation and
that a specific questionnaire should be preferred. The
use of EQ-5D cannot be recommended for use in cost-
effectiveness studies in the present patient population. It
may be better suited for shoulder patients who are
expected to be more disabled, by example patients with
comminute fractures of the humeral head [44].
Construct validity
In the present study, the construct validity was evaluated
using both the correlation between instruments and the
new criteria of the COSMIN group [32]. Previous studies
have using correlation have reported good construct val-
idity for OISS [6,20], WOSI [2,20,37-40], and EuroQol
[21,22,24,41,45]. We found WOSI and OISS to be ac-
ceptably correlated for both diagnostic groups, which
suggests that the self-report questionnaires can be used
interchangeably. The EQ-5D, EQ-VAS, and Rowe score
correlated < 0.60 with the specific questionnaires in
both groups, which suggests that different constructs
are measured. Applying the COSMIN checklist, OISS
was acceptable for the two aspects of construct validity,
but none of the questionnaires had acceptable conver-
gent validity, but the use of hypotheses for the evalu-
ation of construct validity is preferable, according to
the COSMIN group [32] and to Guyatt [35]. The use of
specific hypotheses also reduces the risk of bias, as
stated by Terwee et al. [17], by avoiding the possibility
of the retrospective construction of alternative explana-
tions for the observed correlations. Nevertheless, the
number of hypotheses applied can influence conclu-
sions about validity.
Advantages and limitations of the study
The main advantages of the present study, in compari-
son with previous studies, are the evaluation of the
scores according to recommendations in the COSMIN
checklist. Although patients with SLAP lesions and pa-
tients with instability are comparable on most items,differences appeared [9]. One limitation of the current
study is that the sample size of each diagnostic group is
small; however no major differences appeared between
groups. For future studies, including responsiveness, lar-
ger studies for each diagnostic group are recommended.
Conclusion
The measurement error and aspects of construct validity
should be considered when OISS and WOSI are used in
patients with recurrent shoulder dislocation and patients
with SLAP-lesions. EQ-5D is not to be recommended as
a single outcome instrument. The different methods for
estimating SEM is a challenge when comparing meas-
urement errors across studies.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ØS participated in the design of the study, drafted the manuscript, and
evaluated patients for inclusion and follow-up exams. SL participated in the
design of the study, presided the translation- and cross cultural adaptation
process and helped to draft the manuscript. OR participated in the design of
the study, contributed in monitoring the trial and drafting the manuscript.
PM participated in the design of the study, planned and preformed the
statistical analysis. JIB participated in the design of the study, monitored the
trial, contributed to the translation- and cross cultural adaptation process,
and helped with drafting the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
We would like to thank Alastair Collins, Shari Gerber Nilsen, Susan Schanche
for their contribution on the translation and cross cultural adaptation process
of OISS and WOSI, and surgical director Lars Vasli, and colleagues and staff at
Lovisenberg Diaconal Hospital who allowed us to conduct this trial.
Author details
1Department of Orthopedic Surgery, Lovisenberg Diaconal Hospital,
Lovisenberggaten 17, 0440, Oslo, Norway. 2Department of Orthopedic
Surgery, Sørlandet Hospital- Arendal, Sykehusveien 1, 4838, Arendal, Norway.
3Department of Orthopedic Surgery, Oslo University Hospital-Rikshospitalet,
Sognsvannsveien, 0027, Oslo, Norway. 4Department of Pediatrics, Oslo
University Hospital- Ullevål, 0407, Oslo, Norway.
Received: 30 April 2013 Accepted: 8 July 2013
Published: 15 July 2013
References
1. Ekeberg OM, Bautz-Holter E, Keller A, Tveita EK, Juel NG, Brox JI: A
questionnaire found disease-specific WORC index is not more
responsive than SPADI and OSS in rotator cuff disease. J Clin Epidemiol
2010, 63:575–584.
2. Kirkley A, Griffin S, McLintock H, Ng L: The development and evaluation of
a disease-specific quality of life measurement tool for shoulder
instability. The Western Ontario Shoulder Instability Index (WOSI). Am J
Sports Med 1998, 26:764–772.
3. Jaggi A, Lambert S: Rehabilitation for shoulder instability. Br J Sports Med
2010, 44:333–340.
4. Owens BD, Nelson BJ, Duffey ML, Mountcastle SB, Taylor DC, Cameron KL, et
al: Pathoanatomy of first-time, traumatic, anterior glenohumeral
subluxation events. J Bone Joint Surg Am 2010, 92:1605–1611.
5. Dawson J, Fitzpatrick R, Carr A: Questionnaire on the perceptions of
patients about shoulder surgery. J Bone Joint Surg Br 1996, 78:593–600.
6. Dawson J, Fitzpatrick R, Carr A: The assessment of shoulder instability. The
development and validation of a questionnaire. J Bone Joint Surg Br 1999,
81:420–426.
Skare et al. BMC Research Notes 2013, 6:273 Page 10 of 10
http://www.biomedcentral.com/1756-0500/6/2737. Snyder SJ, Karzel RP, Del PW, Ferkel RD, Friedman MJ: SLAP lesions of the
shoulder. Arthroscopy 1990, 6:274–279.
8. Schroder CP, Skare O, Gjengedal E, Uppheim G, Reikeras O, Brox JI: Long-
term results after SLAP repair: a 5-year follow-up study of 107 patients
with comparison of patients aged over and under 40 years. Arthroscopy
2012, 28:1601–1607.
9. Skare O, Schroder CP, Mowinckel P, Reikeras O, Brox JI: Reliability,
agreement and validity of the 1988 version of the Rowe Score. J Shoulder
Elbow Surg 2011, 20:1041–1049.
10. Rouleau DM, Faber K, MacDermid JC: Systematic review of patient-
administered shoulder functional scores on instability. J Shoulder Elbow
Surg 2010, 19:1121–1128.
11. Beaton D, Richards RR: Assessing the reliability and responsiveness of 5
shoulder questionnaires. J Shoulder Elbow Surg 1998, 7:565–572.
12. Brooks R: EuroQol: the current state of play. Health Policy 1996, 37:53–72.
13. Oh JH, Jo KH, Kim WS, Gong HS, Han SG, Kim YH: Comparative evaluation
of the measurement properties of various shoulder outcome
instruments. Am J Sports Med 2009, 37:1161–1168.
14. Wright RW, Baumgarten KM: Shoulder outcomes measures. J Am Acad
Orthop Surg 2010, 18:436–444.
15. Diehr P, Chen L, Patrick D, Feng Z, Yasui Y: Reliability, effect size, and
responsiveness of health status measures in the design of randomized
and cluster-randomized trials. Contemp Clin Trials 2005, 26:45–58.
16. Lachin JM: The role of measurement reliability in clinical trials. Clin Trials
2004, 1:553–566.
17. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al:
Quality criteria were proposed for measurement properties of health
status questionnaires. J Clin Epidemiol 2007, 60:34–42.
18. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al:
The COSMIN checklist for assessing the methodological quality of
studies on measurement properties of health status measurement
instruments: an international Delphi study. Qual Life Res 2010, 19:539–549.
19. Loughead JM, Williams JR: Outcome following Bankart repair for shoulder
instability 1998–2002 using a subjective patient based shoulder
questionnaire (Oxford). Injury 2005, 36:539–543.
20. Bot SD, Terwee CB, van der Windt DA, Bouter LM, Dekker J, de Vet HC:
Clinimetric evaluation of shoulder disability questionnaires: a systematic
review of the literature. Ann Rheum Dis 2004, 63:335–341.
21. Brazier J, Jones N, Kind P: Testing the validity of the Euroqol and
comparing it with the SF-36 health survey questionnaire. Qual Life Res
1993, 2:169–180.
22. Essink-Bot ML, Krabbe PF, Bonsel GJ, Aaronson NK: An empirical
comparison of four generic health status measures. The Nottingham
Health Profile, the Medical Outcomes Study 36-item Short-Form Health
Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care
1997, 35:522–537.
23. Rowe CR: Evaluation of the Shoulder, The Shoulder. New York: Churchill
Livingstone; 1988:631–637.
24. Nord E: EuroQol: health-related quality of life measurement. Valuations
of health states by the general public in Norway. Health Policy 1991,
18:25–36.
25. Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the
process of cross-cultural adaptation of self-report measures. Spine (Phila
Pa 1976) 2000, 25:3186–3191.
26. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-
related quality of life measures: literature review and proposed
guidelines. J Clin Epidemiol 1993, 46:1417–1432.
27. Altman DG: Practical statistics for medical research. London: Chapman & Hall;
1991:402–403.
28. Weir JP: Quantifying test-retest reliability using the intraclass correlation
coefficient and the SEM. J Strength Cond Res 2005, 19:231–240.
29. Keller A, Hellesnes J, Brox JI: Reliability of the isokinetic trunk extensor
test, Biering-Sorensen test, and Astrand bicycle test: assessment of
intraclass correlation coefficient and critical difference in patients with
chronic low back pain and healthy individuals. Spine (Phila Pa 1976) 2001,
26:771–777.
30. Bland JM, Altman DG: Measurement error. BMJ 1996, 313:744.
31. Hinton-Bayre AD: Specificity of reliable change models and review of the
within-subjects standard deviation as an error term. Arch Clin
Neuropsychol 2011, 26:67–75.32. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al:
The COSMIN checklist for evaluating the methodological quality of
studies on measurement properties: a clarification of its content. BMC
Med Res Methodol 2010, 10:22.
33. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al:
The COSMIN study reached international consensus on taxonomy,
terminology, and definitions of measurement properties for health-
related patient-reported outcomes. J Clin Epidemiol 2010, 63:737–745.
34. Bland JM, Altman DG: Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986, 1:307–310.
35. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life.
Ann Intern Med 1993, 118:622–629.
36. CAMPBELL DT, FISKE DW: Convergent and discriminant validation by the
multitrait-multimethod matrix. Psychol Bull 1959, 56:81–105.
37. Cacchio A, Paoloni M, Griffin SH, Rosa F, Properzi G, Padua L, et al: Cross-
cultural adaptation and measurement properties of an Italian version of
the Western Ontario Shoulder Instability Index (WOSI). J Orthop Sports
Phys Ther 2012, 42:559–567.
38. Hatta T, Shinozaki N, Omi R, Sano H, Yamamoto N, Ando A, et al: Reliability
and validity of the Western Ontario Shoulder Instability Index (WOSI) in
the Japanese population. J Orthop Sci 2011, 16:732–736.
39. Hofstaetter JG, Hanslik-Schnabel B, Hofstaetter SG, Wurnig C, Huber W:
Cross-cultural adaptation and validation of the German version of the
Western Ontario Shoulder Instability index. Arch Orthop Trauma Surg
2010, 130:787–796.
40. Salomonsson B, Ahlstrom S, Dalen N, Lillkrona U: The Western Ontario
Shoulder Instability Index (WOSI): validity, reliability, and responsiveness
retested with a Swedish translation. Acta Orthop 2009, 80:233–238.
41. Adobor RD, Rimeslatten S, Keller A, Brox JI: Repeatability, reliability, and
concurrent validity of the scoliosis research society-22 questionnaire and
EuroQol in patients with adolescent idiopathic scoliosis. Spine (Phila Pa
1976) 2010, 35:206–209.
42. Moser JS, Barker KL, Doll HA, Carr AJ: Comparison of two patient-based
outcome measures for shoulder instability after nonoperative treatment.
J Shoulder Elbow Surg 2008, 17:886–892.
43. Brooks RG, Jendteg S, Lindgren B, Persson U, Bjork S: EuroQol: health-
related quality of life measurement. Results of the Swedish
questionnaire exercise. Health Policy 1991, 18:37–48.
44. Launonen AP, Lepola V, Flinkkila T, Strandberg N, Ojanpera J, Rissanen P,
et al: Conservative treatment, plate fixation, or prosthesis for proximal
humeral fracture. A prospective randomized study. BMC Musculoskelet
Disord 2012, 13:167.
45. Solberg TK, Olsen JA, Ingebrigtsen T, Hofoss D, Nygaard OP: Health-related
quality of life assessment by the EuroQol-5D can provide cost-utility
data in the field of low-back surgery. Eur Spine J 2005, 14:1000–1007.
doi:10.1186/1756-0500-6-273
Cite this article as: Skare et al.: Evaluation of Oxford instability shoulder
score, Western Ontario shoulder instability Index and Euroqol in
patients with slap (superior labral anterior posterior) lesions or recurrent
anterior dislocations of the shoulder. BMC Research Notes 2013 6:273.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
